RxFunction Welcomes New Director -- Robert P.

Rinek of Piper Jaffray Joins

RxFunctions Board of Directors

This is a very exciting opportunity. There is a great clinical need out there that RxFunction is
uniquely positioned to address, said Robert P. Rinek, board member of RxFunction.

Minneapolis, MN, September 19, 2017 --(PR.com)-- RxFunction, Inc. is the manufacturer of Walkasins
, the first Wearable Sensory Prosthesis (WSP) to help improve balance in patients who experience
gait and balance problems due to peripheral neuropathy.

This is a very exciting opportunity. There is a great clinical need out there that RxFunction is uniquely
positioned to address, said Robert P. Rinek, board member of RxFunction.

Rinek brings 35 years of experience in the investment banking and private equity industry to
RxFunction's board. He is currently a managing director in the Piper Jaffray merchant banking group,
co-CEO of PJC Capital Partners LLC and a member of the general partner. In the late 1980s, Rinek
established Piper Jaffray's financial institutions group within investment banking, and served as the
group's global head until December 2007. He was with the Northern Trust Company and ITT Financial
Corporation before joining Piper Jaffray in 1982. Rinek is also a former board member of Piper Jaffray
Ventures. He is a founding member of Twin Cities Angels, an angel investment group in Minneapolis/St.
Paul, and he has served on the board of Marshall Financial Ventures, an equity fund that invests in
late-stage financial services companies.

Currently, Rinek is either on the board of, or has board observation responsibility for the following
portfolio companies: Living Proof, PerfectServe, Harvest Power, LogRhythm and Brainyak, Inc.

Rinek is a graduate of Denison University and the University of Chicago Booth School of Business where
he earned his Master of Business Administration degree. He also holds the Certified Management
Accountant (CMA) professional designation, and has served on the boards of numerous for-profit and
non-profit organizations.

I'm impressed with how RxFunction has been able to receive grant funding from NIH to develop this
novel technology - that is not easy, said Rinek. I look forward to working with this innovative company
and help bring their technology to the market and patients in need.

Bob brings deep professional experience to the company, said Dan Leach, CEO and co-founder of
RxFunction. We are happy and fortunate that he has joined our board of directors. He is precisely who
we need involved at this stage of our development.

An estimated 20 million Americans have some form of peripheral neuropathy, according to the
Foundation for Peripheral Neuropathy, commonly as a consequence of diabetes or chemotherapy. These
patients may lose sensation in their feet, which affects balance and increases fall risk. Walkasins detect
when the wearer begins to lose balance and send a signal to a cuff worn around the calf. The cuff vibrates

Page 1/3
PR.com Press Release Distribution Terms of Use
to help the wearer know which way they are leaning, allowing them to correct their balance.

Walkasins help replace some of these patients' lost sensory information that is important for balance,
said Dr. Lars Oddsson, co-inventor of the technology and president of RxFunction. Our recent data from
the Minneapolis VA show that some patients display immediate meaningful improvement in clinical
outcomes, which really is amazing.

Development of Walkasins has been supported by a Small Business Innovation Research (SBIR) grant
from the NIH (AG040865).

About RxFunction, Inc.

RxFunction is a wearable technology company with an initial focus on developing and leading a new
business segment within the U.S. medical grade assistive technology marketplace. The company's vision
is to improve physical ability for social participation and quality of life. Privately held and headquartered
in Minneapolis, MN, RxFunction has taken assignment of patented technology developed by co-founder
Dr. Lars Oddsson as a research professor at Boston University's Neuromuscular Research Center, and
funded by Edina, MN investment bank, Cedar Point Capital, and the NIH's National Institute on Aging.
Walkasins have not been submitted to the FDA for review, and are not available for sale at this time.

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
RxFunction, Inc.
Dan Leach
612-800-9950
Contact via Email
www.walkasins.com
5201 Eden Avenue, #300
Edina, MN 55436

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/730422

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use